Co-Authors
This is a "connection" page, showing publications co-authored by Markus Hoffmann and Inga Nehlmeier.
Connection Strength
0.283
-
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination. Cell Rep. 2021 07 20; 36(3):109415.
Score: 0.238
-
Different residues in the SARS-CoV spike protein determine cleavage and activation by the host cell protease TMPRSS2. PLoS One. 2017; 12(6):e0179177.
Score: 0.045